TransCode Therapeutics Inc (NASDAQ:RNAZ) currently has a daily average trading volume of 987.96K but it saw 1446808 shares traded in last market. With a market cap of 4.97M USD, the company’s current market price of $0.29 came rising about 4.31 while comparing to the previous closing price of $0.28. In past 52 weeks, the stock remained buoying in the range of price level as high as $128.00 and as low as $0.22. In the recent trading on the day, stock has struck highest price mark of $0.25 while lowest mark touched by it was $0.2899.
Taking a look at 20-day trading activity of TransCode Therapeutics Inc (RNAZ) gives us an average price of $0.2652, while its current price level is -99.78% below from 52-week high level whereas it is 33.29% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5693 while that of 200 days or SMA-200 reads an average of $2.3490. A closer look into the stock’s movement over the week reveals that its volatility is standing at 9.42% during that period while stretching the period over a month that decreases to 9.25%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 36.39 which implies that the stock is in neutral territory.
Over the week, RNAZ’s stock price is moving 2.97% up while it is 6.63% when we observe its performance for the past one month. Year-to-date it is -95.63% down and over the past year, the stock is showing a downside performance of -99.57%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of -67.2 beaten by the consensus estimate of -60 for the same. The company is expected to be releasing its next quarterly report on 2024-Aug-14, for which analysts forecasted an EPS of -0.51 while estimate for next year EPS is -2.05.
Currently, TransCode Therapeutics Inc’s total number of outstanding shares is 17.27M with 0.05% of that held by the insiders while 11.46% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -1354.12% and return on equity (ROE) at -1048.70%. Stock’s beta reads 0.47. Stock has a price to book (P/B) ratio of 1.58. Its return on asset (ROA) is -334.48% on average.
